Asset Details
Do you wish to reserve the book?
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
Do you wish to request the book?
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
2007
Overview
Rotavirus is a major cause of gastroenteritis in young children. New vaccines for rotavirus are now available and countries need to establish the health and economic burden of rotavirus disease to assess whether vaccine introduction is advisable. This study assesses the fraction of acute gastroenteritis in children under 5 years that may be attributable to rotavirus using multiple linear regression. Results suggest around 45% of hospitalisations, 25% of GP consultations, 27% of NHS Direct calls and 20% of accident and emergency (A&E) attendances for acute gastroenteritis in this age group may be attributable to rotavirus. The annual incidence is estimated to be 4.5 hospitalisations, 9.3 A&E consultations, and 28-44 GP consultations per 1000 children under five years of age. The cost to the health service is estimated to be pound 14.2m per annum. Rotavirus vaccination has the potential to reduce this burden of disease. This study provides a sound basis on which to make this assessment and serves as a baseline against which any reductions that do occur if vaccination is introduced can be measured against.
Publisher
Elsevier,Elsevier Limited
Subject
/ Biological and medical sciences
/ Diarrhea
/ Fundamental and applied biological sciences. Psychology
/ Gastroenteritis - epidemiology
/ Gastroenteritis - prevention & control
/ Hospitalization - statistics & numerical data
/ Humans
/ Infant
/ Rotavirus Infections - economics
/ Rotavirus Infections - epidemiology
/ Rotavirus Infections - prevention & control
/ Rotavirus Vaccines - administration & dosage
/ Rotavirus Vaccines - economics
/ Software
/ Vaccines
/ Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
/ Virology
/ Viruses
